DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,149,674 | +3.8% | 113,461 | +0.4% | 0.40% | +6.9% |
| Q2 2023 | $27,110,640 | -6.8% | 112,961 | -2.1% | 0.38% | -10.5% |
| Q1 2023 | $29,075,587 | -4.7% | 115,361 | +0.3% | 0.42% | -13.2% |
| Q4 2022 | $30,525,423 | +1.9% | 115,008 | -0.9% | 0.48% | -3.2% |
| Q3 2022 | $29,963,000 | +2.3% | 116,006 | +0.4% | 0.50% | +6.6% |
| Q2 2022 | $29,287,000 | -11.8% | 115,522 | +2.0% | 0.47% | +6.1% |
| Q1 2022 | $33,211,000 | -12.2% | 113,222 | -1.6% | 0.44% | -5.6% |
| Q4 2021 | $37,843,000 | +8.3% | 115,022 | +0.2% | 0.47% | -1.1% |
| Q3 2021 | $34,956,000 | +7.7% | 114,822 | -5.0% | 0.47% | +13.2% |
| Q2 2021 | $32,450,000 | +19.8% | 120,922 | +0.5% | 0.42% | +10.9% |
| Q1 2021 | $27,082,000 | -3.0% | 120,322 | -4.2% | 0.38% | -4.8% |
| Q4 2020 | $27,906,000 | +7.8% | 125,622 | +4.5% | 0.40% | -7.9% |
| Q3 2020 | $25,887,000 | +22.6% | 120,222 | +0.7% | 0.43% | +10.8% |
| Q2 2020 | $21,117,000 | +26.5% | 119,422 | -1.0% | 0.39% | +7.5% |
| Q1 2020 | $16,696,000 | -9.8% | 120,622 | 0.0% | 0.36% | +11.1% |
| Q4 2019 | $18,513,000 | +5.9% | 120,622 | -0.3% | 0.32% | -2.4% |
| Q3 2019 | $17,479,000 | +1.8% | 121,022 | +0.7% | 0.33% | +1.2% |
| Q2 2019 | $17,168,000 | +9.7% | 120,122 | +1.3% | 0.33% | +6.1% |
| Q1 2019 | $15,654,000 | +31.7% | 118,571 | +2.8% | 0.31% | +15.2% |
| Q4 2018 | $11,890,000 | -4.8% | 115,303 | +0.3% | 0.27% | +11.2% |
| Q3 2018 | $12,496,000 | +10.7% | 115,003 | +0.5% | 0.24% | +3.4% |
| Q2 2018 | $11,289,000 | +1.0% | 114,403 | +0.2% | 0.23% | -1.7% |
| Q1 2018 | $11,181,000 | +5.7% | 114,203 | +0.2% | 0.24% | +7.2% |
| Q4 2017 | $10,581,000 | +9.6% | 114,003 | +1.3% | 0.22% | +2.3% |
| Q3 2017 | $9,650,000 | +1.8% | 112,503 | +0.2% | 0.22% | -1.8% |
| Q2 2017 | $9,477,000 | -0.1% | 112,303 | +1.3% | 0.22% | -2.6% |
| Q1 2017 | $9,486,000 | +9.9% | 110,903 | 0.0% | 0.23% | +4.6% |
| Q4 2016 | $8,633,000 | -0.7% | 110,903 | 0.0% | 0.22% | -3.6% |
| Q3 2016 | $8,694,000 | -22.4% | 110,903 | 0.0% | 0.22% | -24.5% |
| Q2 2016 | $11,201,000 | +10.2% | 110,903 | +3.5% | 0.30% | +8.0% |
| Q1 2016 | $10,160,000 | +2.3% | 107,103 | +0.2% | 0.28% | +2.6% |
| Q4 2015 | $9,930,000 | +9.1% | 106,903 | +0.1% | 0.27% | +3.1% |
| Q3 2015 | $9,100,000 | -3.6% | 106,803 | -3.2% | 0.26% | +4.0% |
| Q2 2015 | $9,441,000 | +2.4% | 110,303 | +1.6% | 0.25% | +3.7% |
| Q1 2015 | $9,221,000 | +2.3% | 108,603 | +3.2% | 0.24% | -2.4% |
| Q4 2014 | $9,017,000 | +12.8% | 105,203 | 0.0% | 0.25% | +8.3% |
| Q3 2014 | $7,994,000 | -3.7% | 105,203 | -0.2% | 0.23% | -3.8% |
| Q2 2014 | $8,298,000 | +2.8% | 105,403 | -2.0% | 0.24% | +2.1% |
| Q1 2014 | $8,071,000 | -2.1% | 107,603 | +0.7% | 0.23% | -4.5% |
| Q4 2013 | $8,245,000 | +11.4% | 106,803 | 0.0% | 0.24% | +1.7% |
| Q3 2013 | $7,403,000 | +8.6% | 106,803 | -0.8% | 0.24% | +4.3% |
| Q2 2013 | $6,818,000 | – | 107,703 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |